{"data":[{"accessionNo":"0001274173-26-000187","formType":"SCHEDULE 13G/A","amendmentNo":11,"issuerCik":"0001649094","issuerName":"VAXCYTE, INC.","ticker":"PCVX","cusip":"92243G108","securityClass":"Common Stock","eventDate":"2026-07-31","reportingPerson":"JANUS HENDERSON GROUP Ltd.","reportingCik":null,"personType":"HC","sharesOwned":18040375,"percentOfClass":12.1,"filedAt":"2026-08-11","canonicalUrl":"https://xoomar.com/markets/stocks/pcvx"},{"accessionNo":"0001274173-26-000184","formType":"SCHEDULE 13G/A","amendmentNo":10,"issuerCik":"0001649094","issuerName":"VAXCYTE, INC.","ticker":"PCVX","cusip":"92243G108","securityClass":"Common Stock","eventDate":"2026-07-31","reportingPerson":"JANUS HENDERSON GROUP Ltd.","reportingCik":null,"personType":"HC","sharesOwned":65694,"percentOfClass":0.1,"filedAt":"2026-08-07","canonicalUrl":"https://xoomar.com/markets/stocks/pcvx"},{"accessionNo":"0000315066-26-002158","formType":"SCHEDULE 13G/A","amendmentNo":10,"issuerCik":"0001649094","issuerName":"VAXCYTE INC","ticker":"PCVX","cusip":"92243G108","securityClass":"COMMON STOCK","eventDate":"2026-06-30","reportingPerson":"FMR LLC","reportingCik":null,"personType":"HC","sharesOwned":20798906.96,"percentOfClass":14.4,"filedAt":"2026-08-06","canonicalUrl":"https://xoomar.com/markets/stocks/pcvx"},{"accessionNo":"0000315066-26-002158","formType":"SCHEDULE 13G/A","amendmentNo":10,"issuerCik":"0001649094","issuerName":"VAXCYTE INC","ticker":"PCVX","cusip":"92243G108","securityClass":"COMMON STOCK","eventDate":"2026-06-30","reportingPerson":"Abigail P. Johnson","reportingCik":null,"personType":"IN","sharesOwned":20798906.96,"percentOfClass":14.4,"filedAt":"2026-08-06","canonicalUrl":"https://xoomar.com/markets/stocks/pcvx"},{"accessionNo":"0001274173-26-000145","formType":"SCHEDULE 13G/A","amendmentNo":9,"issuerCik":"0001649094","issuerName":"VAXCYTE, INC.","ticker":"PCVX","cusip":"92243G108","securityClass":"Common Stock","eventDate":"2026-03-31","reportingPerson":"JANUS HENDERSON GROUP PLC","reportingCik":null,"personType":"HC","sharesOwned":16575875,"percentOfClass":11.5,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/pcvx"},{"accessionNo":"0001346824-26-000161","formType":"SCHEDULE 13G/A","amendmentNo":7,"issuerCik":"0001649094","issuerName":"VAXCYTE, INC.","ticker":"PCVX","cusip":"92243G108","securityClass":"Common Stock, $0.001 par value per share","eventDate":"2026-03-31","reportingPerson":"Peter Kolchinsky","reportingCik":null,"personType":"HC,IN","sharesOwned":12974599,"percentOfClass":8.9,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/pcvx"},{"accessionNo":"0001346824-26-000161","formType":"SCHEDULE 13G/A","amendmentNo":7,"issuerCik":"0001649094","issuerName":"VAXCYTE, INC.","ticker":"PCVX","cusip":"92243G108","securityClass":"Common Stock, $0.001 par value per share","eventDate":"2026-03-31","reportingPerson":"Rajeev Shah","reportingCik":null,"personType":"HC,IN","sharesOwned":12974599,"percentOfClass":8.9,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/pcvx"},{"accessionNo":"0001346824-26-000161","formType":"SCHEDULE 13G/A","amendmentNo":7,"issuerCik":"0001649094","issuerName":"VAXCYTE, INC.","ticker":"PCVX","cusip":"92243G108","securityClass":"Common Stock, $0.001 par value per share","eventDate":"2026-03-31","reportingPerson":"RA Capital Management, L.P.","reportingCik":null,"personType":"IA,PN","sharesOwned":12974599,"percentOfClass":8.9,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/pcvx"},{"accessionNo":"0001346824-26-000161","formType":"SCHEDULE 13G/A","amendmentNo":7,"issuerCik":"0001649094","issuerName":"VAXCYTE, INC.","ticker":"PCVX","cusip":"92243G108","securityClass":"Common Stock, $0.001 par value per share","eventDate":"2026-03-31","reportingPerson":"RA Capital Healthcare Fund, L.P.","reportingCik":null,"personType":"PN","sharesOwned":12699089,"percentOfClass":8.7,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/pcvx"},{"accessionNo":"0000315066-26-001307","formType":"SCHEDULE 13G/A","amendmentNo":9,"issuerCik":"0001649094","issuerName":"VAXCYTE INC","ticker":"PCVX","cusip":"92243G108","securityClass":"COMMON STOCK","eventDate":"2026-03-31","reportingPerson":"FMR LLC","reportingCik":null,"personType":"HC","sharesOwned":16451061.32,"percentOfClass":11.4,"filedAt":"2026-05-06","canonicalUrl":"https://xoomar.com/markets/stocks/pcvx"},{"accessionNo":"0000315066-26-001307","formType":"SCHEDULE 13G/A","amendmentNo":9,"issuerCik":"0001649094","issuerName":"VAXCYTE INC","ticker":"PCVX","cusip":"92243G108","securityClass":"COMMON STOCK","eventDate":"2026-03-31","reportingPerson":"Abigail P. Johnson","reportingCik":null,"personType":"IN","sharesOwned":16451061.32,"percentOfClass":11.4,"filedAt":"2026-05-06","canonicalUrl":"https://xoomar.com/markets/stocks/pcvx"},{"accessionNo":"0002100119-26-001191","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001649094","issuerName":"Vaxcyte Inc","ticker":"PCVX","cusip":"92243G108","securityClass":"Common Stock","eventDate":"2026-03-31","reportingPerson":"Vanguard Capital Management","reportingCik":null,"personType":"IA","sharesOwned":7252053,"percentOfClass":5.03,"filedAt":"2026-04-30","canonicalUrl":"https://xoomar.com/markets/stocks/pcvx"},{"accessionNo":"0000102909-26-002593","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001649094","issuerName":"Vaxcyte Inc","ticker":"PCVX","cusip":"92243G108","securityClass":"Common Stock","eventDate":"2026-03-13","reportingPerson":"The Vanguard Group","reportingCik":null,"personType":"IA","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-03-27","canonicalUrl":"https://xoomar.com/markets/stocks/pcvx"},{"accessionNo":"0001897612-26-000276","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001649094","issuerName":"VAXCYTE INC","ticker":"PCVX","cusip":null,"securityClass":"COMMON STOCK","eventDate":"2025-12-31","reportingPerson":"T. Rowe Price Investment Management, Inc.","reportingCik":null,"personType":"IA","sharesOwned":11296333,"percentOfClass":8.6,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/pcvx"},{"accessionNo":"0001274173-25-000292","formType":"SCHEDULE 13G/A","amendmentNo":8,"issuerCik":"0001649094","issuerName":"VAXCYTE, INC.","ticker":"PCVX","cusip":null,"securityClass":"Common Stock","eventDate":"2025-09-30","reportingPerson":"JANUS HENDERSON GROUP PLC","reportingCik":null,"personType":"IA,HC","sharesOwned":13104203,"percentOfClass":10.1,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/pcvx"},{"accessionNo":"0001897612-25-000545","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001649094","issuerName":"VAXCYTE INC","ticker":"PCVX","cusip":null,"securityClass":"COMMON STOCK","eventDate":"2025-09-30","reportingPerson":"T. Rowe Price Investment Management, Inc.","reportingCik":null,"personType":"IA","sharesOwned":8315476,"percentOfClass":6.4,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/pcvx"}],"updatedAt":"2026-10-29T10:52:08.164Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/pcvx","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}